04 Oct 2019
A newly developed drug for treating metabolic syndrome safely reduces plasma triglycerides and LDL cholesterol, and reverses NAFLD and liver insulin resistance, according to a study published in Science Translational Medicine.
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024
Would you like to host the BSPED annual meeting?
21 Oct 2024